Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001209191-23-031873 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-22 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $10.12 | -6,305 | 219.3K | -3% | -$63.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-22 | S | D | 6,305 | $10.12 | 219,327 | D | — | — |